These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24398041)

  • 1. Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart.
    Wu X; Sagave J; Rutkovskiy A; Haugen F; Baysa A; Nygård S; Czibik G; Dahl CP; Gullestad L; Vaage J; Valen G
    Life Sci; 2014 Mar; 97(2):145-54. PubMed ID: 24398041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans.
    Rutkovskiy A; Sagave J; Czibik G; Baysa A; Zihlavnikova Enayati K; Hillestad V; Dahl CP; Fiane A; Gullestad L; Gravning J; Ahmed S; Attramadal H; Valen G; Vaage J
    Scand J Clin Lab Invest; 2017 Sep; 77(5):321-331. PubMed ID: 28460577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin-1 in cardiac endothelial cells is downregulated in ischemia, hypoxia and cardioplegia.
    Rutkovskiy A; Bliksøen M; Hillestad V; Amin M; Czibik G; Valen G; Vaage J; Amiry-Moghaddam M; Stensløkken KO
    J Mol Cell Cardiol; 2013 Mar; 56():22-33. PubMed ID: 23238222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes.
    Pfister O; Lorenz V; Oikonomopoulos A; Xu L; Häuselmann SP; Mbah C; Kaufmann BA; Liao R; Wodnar-Filipowicz A; Kuster GM
    J Am Coll Cardiol; 2014 Mar; 63(10):1011-9. PubMed ID: 24184252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium.
    Mathura JR; Jafari N; Chang JT; Hackett SF; Wahlin KJ; Della NG; Okamoto N; Zack DJ; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):592-600. PubMed ID: 10670493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
    Xuan W; Wu B; Chen C; Chen B; Zhang W; Xu D; Bin J; Liao Y
    Crit Care Med; 2012 Nov; 40(11):3026-33. PubMed ID: 22926332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effect of fractalkine on myocardial ischaemia and heart failure.
    Xuan W; Liao Y; Chen B; Huang Q; Xu D; Liu Y; Bin J; Kitakaze M
    Cardiovasc Res; 2011 Dec; 92(3):385-93. PubMed ID: 21840883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aquaporin-4 in the heart: expression, regulation and functional role in ischemia.
    Rutkovskiy A; Stensløkken KO; Mariero LH; Skrbic B; Amiry-Moghaddam M; Hillestad V; Valen G; Perreault MC; Ottersen OP; Gullestad L; Dahl CP; Vaage J
    Basic Res Cardiol; 2012 Sep; 107(5):280. PubMed ID: 22777185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure.
    Song G; Campos B; Wagoner LE; Dedman JR; Walsh RA
    J Mol Cell Cardiol; 1998 Mar; 30(3):443-51. PubMed ID: 9515022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
    Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
    Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1: the missing link between diabetes mellitus and heart failure.
    Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
    Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 antagonizes bone morphogenetic protein-4 induced cardiomyocyte hypertrophy and apoptosis.
    Lu J; Sun B; Huo R; Wang YC; Yang D; Xing Y; Xiao XL; Xie X; Dong DL
    J Cell Physiol; 2014 Oct; 229(10):1503-10. PubMed ID: 24648278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of bone morphogenetic proteins in the development of the embryonic endocardial cushions.
    Keyes WM; Logan C; Parker E; Sanders EJ
    Anat Embryol (Berl); 2003 Sep; 207(2):135-47. PubMed ID: 12905017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.
    Alarmo EL; Kuukasjärvi T; Karhu R; Kallioniemi A
    Breast Cancer Res Treat; 2007 Jun; 103(2):239-46. PubMed ID: 17004110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.
    Joki Y; Ohashi K; Yuasa D; Shibata R; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ito M; Ogawa H; Daida H; Murohara T; Ouchi N
    Circ Heart Fail; 2015 Mar; 8(2):342-51. PubMed ID: 25654972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway.
    Pachori AS; Custer L; Hansen D; Clapp S; Kemppa E; Klingensmith J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1255-65. PubMed ID: 20096288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
    Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
    Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.